Press release
Some of Scotland’s brightest business prospects are preparing for an exciting future after being crowned winners of a major Scottish competition.
Stories in School of Life Sciences
25 results
Press release
University of Dundee researcher Professor Doreen Cantrell has been appointed as a trustee of one of the world’s biggest cancer charities.
News
UK Biobank recently announced the appointment of Professor Sir Michael Ferguson to its Board.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
News
Dr Susan Wyllie, Head of the Mode of Action group within WCAIR and Principal Investigator in the School of Life Sciences, underwent a successful tenure review recently.
Press release
A University of Dundee researcher is to join an international collaboration that brings scientists from academia together with one of the world’s largest pharma companies to help develop new drugs for cancer and other devastating diseases.
Press release
A new translational research centre will bolster the University of Dundee’s world-leading position in a field that is revolutionising drug discovery, while helping to facilitate the development of high growth companies and create skilled jobs.
Press release
A near-£1 million investment will help University of Dundee spinout company Ten Bio Ltd to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals.
Press release
Amphista Therapeutics, a University of Dundee spinout company, has announced a near-£40 million investment that will further its work to develop new drugs for a range of diseases.
Press release
Work to build on Dundee’s world-class expertise in biomedical sciences is set to begin in earnest after the ‘Growing the Tay Cities Biomedical Cluster’ project was officially signed off by the Tay Cities Region Joint Committee today (February 19).
Press release
A University of Dundee spinout company developing treatments for eczema, rheumatoid arthritis and other inflammatory conditions has completed its first round of private investment.
News
The o2h human health EIS Fund has announced its intention to lead an investment into In4Derm.
Press release
The University of Dundee is to partner with global biopharmaceutical company Almirall to develop new treatments for severe skin diseases with high level of unmet medical need.
Press release
Researchers at the University of Dundee are looking to transform pharmaceutical and cosmetics testing with their spinout venture that offers an alternative for many experiments currently only performed in animals.
News
The finalists for Converge 2020, Scotland’s leading academic company creation programme, have been announced with representation from the School included on the list with Dr Robyn Hickerson, Co-founder and Chief Scientific Officer of Ten Bio.
Press release
University of Dundee researchers hope to turn their spinout venture into a biotech company worth hundreds of millions of pounds by helping to treat people with eczema, rheumatoid arthritis and other inflammatory conditions.
News
Dr. Henry McSorley has joined the School this month as a member of the Division on Cell Signalling and Immunology. He will be joint deputy head of division alongside Hari Hundal.
News
The School has welcomed three new group leaders in recent months. They are currently establishing their laboratories across three of our divisions.
News
Dr Susan Wyllie, Head of the Mode of Action (MoA) group, has been promoted to tenure track Principal Investigator in the School.
News
Kim Dale and Miratul Muqit have been promoted to Personal Chair (Professor) as part of the 2018 Annual Review process for academic staff.